20
Curia Spain Sau, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is PREDNISOLONE SODIUM PHOSPHATE, with a corresponding US DMF Number 22624.
Remarkably, this DMF maintains an Active status since its submission on March 13, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 12, 2014, and payment made on September 12, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II